Capital raising hits new high
Date Time Capital raising hits new high As we enter a new year and reflect on the past 12 months, the metrics show a positive and resilient outcome for the industry with the highest capital raising for life science companies on record. Annual data collected and reported by Bioshares shows that the capital raised by ASX-listed biotech companies in calendar year 2020 was $1.7 billion, building on the $1.08 billion raised the year prior. While the impact of COVID-19 is yet to be realised, the result is looking better than first anticipated for Australian life science companies seeking to commerc...